Speakers

Dr Adcock obtained his PhD in 1987 and joined Professor Peter Barnes’ team in 1990 to work on the molecular mechanisms of glucocorticoid action in the lung.  In 2004 he became Professor of Respiratory Cell & Molecular Biology at Imperial College London.  Dr Adcock’s main research focus is on the regulation of the inflammatory and anti-inflammatory mechanisms underlying severe asthma and COPD.  Recent work has examined the role of epigenetics in airway inflammation and glucocorticoid function and the use of multi-omic analysis to define severe asthma and COPD molecular subphenotypes and drug responses.

Dr Adcock is PI in the U-BIOPRED initiative, Co-PI in the MRC-funded PRISM study to examine biomarkers of responders and non-responders to T2 biologics using multi-omic and single cell approaches. He is a co-PI in the RESPIRE-AI project to develop digital twins to examine the effect of pollution on asthma.

Dr Adcock was formerly Head of Assembly 5 (Airway Diseases) within the ERS and has served on the ERS and ATS Programme Committees. Dr Adcock is currently Chair of the Asthma Section in EAACI and has published >650 papers (H-index = 141).

TBC

Dr Arkwright is a Senior Lecturer/Consultant in Paediatric Allergy & Immunology at the University of Manchester & Royal Manchester Children’s Hospital, United Kingdom. In 2002 he established the tertiary Paediatric Allergy and Immunology service for the North West of England, now recognized as a Centre of Excellence by the World Allergy Organization. He chairs the North West Paediatric Allergy Network. His research interests focus include basic, translational and clinical aspects of atopic dermatitis. He has participated as Principal Investigator on Regeneron Clinical Trials using dupilumab in infants and children. He previously served as Chair of the AAAAI Skin Allergy Interest Group.

He works as part of a multi-disciplinary team looking after children with complex allergies, atopic dermatitis and primary immunodeficiencies, some requiring treatment with immunotherapy, biologics, and stem cell transplantation. He has published 225 Peer-Review original articles with collaborators from around the world. He is currently elected on to the editorial board of JACI In Practice. He lectures and chairs sessions at national and international conferences, including Europe, the Middle, India and Far East as well as the USA. In 2024 he was awarded the William Frankland Award for Outstanding Services in the field of Clinical Allergy in the UK.

Stephen E. Attwood, MD, FRCSI, is honorary professor in health services research at Durham University, UK, and an independent consulting advisor on research and clinical practice for oesophageal diseases. He qualified from Trinity College Dublin and took his Surgical Fellowship at the Royal College of Surgeons in Ireland. Previously, he was a consultant surgeon at Northumbria Healthcare UK.

Since identifying Eosinophilic Oesophagitis (EoE) in 1989 and publishing the first description of the disease in 1992, Professor Attwood has spent his career caring for patients with EoE.  He has been actively engaged in clinical trials of upper gastrointestinal diseases, including budesonide formulations for EoE; the ASPECT trial of cancer prevention in Barrett’s esophagus; BEST3, a study of Cytosponge screening for Barrett’s esophagus in general practices; the BOSS trial of Surveillance endoscopy for early cancer diagnosis in Barrett’s and the LOTUS trial (surgery vs proton pump inhibitor for Gastroesophageal Reflux Disease). He has authored > 200 publications, including the recent BSG Guidelines on EoE.

Heidi is a graduate of Leeds University and has over 25 years of experience working with children with food allergy, currently working as a Senior Specialist Dietitian solely in paediatric allergy as part of the University Hospitals of Leicester Paediatric Allergy Service (outpatient service and day case food challenge programme).

She has also had several publications including for the J R Soc Med, Allergy, J Paed Allergy Clin Immunol and Clinical Experimental Allergy, including her published work on the safety of home baked milk reintroduction in children under 3 years with Ige milk allergy.

She is also the co-author of the BSACI guidelines on the Management of Cow’s Milk Allergy and more recently, the Management of Egg allergy.

She has presented some of her work on selective nut challenges, safety of baked milk reintroduction and the increasing incidence of legume allergy at EACCI / FAAM and BSACI.

Her booklet ‘Food Challenges for Children – a practical guide’ has sold over 1000 copies worldwide and was written to share her knowledge on conducting food challenges with other centres in a safe and practical way.

She also lectures on the Msc Allergy programme (Southampton) and has involvement in resource production for the allergy specialist interest group of the British Dietetic association and is involved in Leicester’s Specific Oral induction programmes for IgE milk and wheat allergy.

Rebecca Batt RGN/RSCN, BSc (Hons) PICU Nursing, MSc Allergy (Imperial College, London), Non-Medical Prescriber (LSBU).

Rebecca’s background includes working for over ten years on PICU at GOSH and The Hospital for Sick Children, Toronto. She was a Nurse Specialist at Asthma UK before beginning her career in allergy in 2007 when she became the Paediatric Allergy CNS at King’s College Hospital, London.

More recently, Rebecca was the ANP before becoming the Nurse Consultant at The Evelina London Children’s Hospital. She is the Senior Clinical Lead for the nurse led service and regularly speaks at national study events and conferences. She also lectures on the ANP Pathway and the Non-Medical Prescribing Course at LSBU. She is a Course Director for the Allergy Academy and runs courses for health professionals working in allergy. She is currently the vice chair of the BSACI Nurses Committee

TBC

TBC

Professor Knut Brockow works at the Department of Dermatology and Allergy, TU Munich, Germany since 1996 and is Honorary Adjunct Professor University of Southern Denmark, Odense, Denmark. He studied medicine in Bonn, trained at the University Hamburg + Munich and was Postdoctoral Research Fellow in the Laboratory of Allergic Diseases, NIAID, NIH in 2000-2001.

Helen Brough is a Consultant in Pediatric Allergy and Immunology at the Evelina Children’s Hospital, St. Thomas’ Hospital, Professor of Pediatric Allergy at King’s College London University, Founder and Director of Children’s Allergy Doctors.

Her professional roles include:

1. Medical Advisor for the Natasha Allergy Research Foundation and Health Advisory Board for Allergy UK
2. Chair of the scientific advisory committee for the Parent and Baby NIHR Programme Grant
3. Member of the expert scientific board member for the NIH-funded CoFAR4 program

Previous roles include:

1. President of the Royal Society of Medicine Allergy and Immunology Section (2022-2024)
2. Chair of the European Academy of Allergy and Clinical Immunology (EAACI) Pediatric Section (2019-2022)
3. Meeting Secretary for the BSACI annual congress (2015-2016)

She is a Principal Investigator for the Stopping Eczema and Allergy (SEAL) study assessing whether proactive skin care in young infants with dry skin or eczema prevents the development of food allergy, the Pronuts study evaluating selective nut eating in nut allergic children, and the Global Assessment of Psychology Services for Food Allergy (GAPS) study. She was a co-investigator on several peanut oral and patch immunotherapy trials. She co-authored the European guidelines for the management of atopic eczema, and the food allergy prevention studies Learning Early About Peanut (LEAP, LEAP-ON, LEAP-Trio) and Enquiring About Tolerance (EAT) study.

Professor Sara Brown is a clinical academic dermatologist, working at the University of Edinburgh and NHS Lothian. Sara trained in Dermatology and Genetics in Newcastle, Dublin and Dundee, before moving to Edinburgh in 2020 where she holds the Grant Chair of Dermatology and a Wellcome Trust Senior Research Fellowship. Sara’s research focuses on understanding molecular genetic mechanisms leading to skin barrier impairment and atopic inflammation, with the aim to translate these findings for drug discovery and therapy development.

Lydia Collins-Hussey is a Specialist Paediatric Allergy Dietitian who has over 12 years’ experience working within the NHS, research, charity and private sector. Her passion lies in supporting families with food allergy and restricted diets. Inspired to make a difference, Lydia regularly facilitates in education and has spoken at hundreds of events nationally and internationally including The Free From Show London, MSc Nutrition programs at Glasgow and Surrey University as well as being part of the Royal College of Paediatrics and Child Health (RCPCH) Paediatric Allergy Training Faculty and a facilitator for the British Dietetic Association (BDA) CMPA course. She is the chair of the committee for the Food Allergy Specialist Group (FASG) and regularly sits on advisory and allergy faculties. She is a member of the British Society of Allergy and Clinical Immunology (BSACI) as well as the European Academy of Allergy and Clinical Immunology (EAACI). In 2019, Lydia won the Barry Kay Award (Allied Health) for her work in CMPA in NHS Grampian and in 2021 won the BDA Paediatric Research Award for her MSc dissertation in CMPA and telehealth.

Adam read Medicine at Cambridge University. He was clinical lead for Allergy (Adult & Paediatric) at Guy’s & St Thomas’ Hospitals, London (2006-2015). After 3 years as Clinical Director for Specialist Ambulatory Medicine, he took up the post of Deputy Medical Director (Commercial) for Guy’s & St Thomas’ Hospitals NHS Foundation Trust in 2018 until 2023. He is also a Professor of Paediatric Allergy at King’s College London and the founding Director of the KCL Allergy Academy, a postgraduate educational programme, which was a finalist at the BMJ Awards in 2018.

Adam was the first paediatrician elected BSACI President (2018-2021), followed by Chair of the National Allergy Strategy Group (2022- ) & he jointly chairs the Expert Advisory Group for Allergy with the Department of Health & Social Care.

Adam’s doctoral thesis on peanut allergy received the Raymond Horton Smith prize from Cambridge University (2012) and he was included in The Times ‘Britain’s 100 Best Children’s Doctor’s’.  Adam received the William Frankland Award in 2015 and National Clinical Excellence awards in 2016 and 2020. In 2024, Adam became the second person to receive the BSACI Fellows Award in recognition of outstanding contribution to clinical allergy.

Dr Jennie Gane is a consultant respiratory physician at the Royal Derby Hospital. Her specialist interests are in severe asthma and general allergy. She trained in the Birmingham Regional Severe Asthma service and West Midlands Allergy and Immunology service at Heartlands Hospital and completed an MSc in Allergy at Imperial College in 2011. She has established an adult allergy service at the Royal Derby Hospital and works within the Nottingham University Hospitals Allergy service. She has an interest in medical education, taking over as chair for the BSACI Allergy Education Network in September 2023 and leading on projects to improve access to high quality allergy education for UK healthcare professionals.

Tomaz has worked as a consultant immunologist in Manchester since 2011. He has a clinical and research interest in anaesthetic drug allergy, hereditary angioedema and immunodeficiency. He is keen to ensure appropriate the use of laboratory diagnostics and worked with colleagues and the Royal College of Pathologists to develop a best practice recommendation article on allergy testing in primary care.

Claudia Gore is a consultant in paediatric allergy and lead for the adolescent allergy service at St Mary’s Hospital, Imperial College Healthcare NHS Trust, London.

Clinically, she has specific expertise in caring for children and young people with complex multisystem allergic disease and severe eczema and in providing as well as expanding services for allergic adolescents.

Her research background includes the role of probiotics and the gut microbiota in infant eczema, quality of life in allergic diseases, nutrition in allergic disease, allergen avoidance measures, eczema treatments, diagnostics and severity monitoring technology.

Claudia’s work in the EAACI adolescent and young adult taskforce and her role as co-chair in the BSACI adolescent and young adult committee support the improvement of care for adolescents and young adults with allergic and other conditions through innovative ways of engaging patients, families, educators, health and care staff:

Dr Grattan is a Consultant Dermatologist at St John’s Institute of Dermatology, Guy’s Hospital, London, UK and Adjunct Professor at Odense University Hospital, Denmark with a special interest in mast cell related disease, especially urticaria.

TBC

Dr Jemma Haines MBE qualified with first-Class Honours in Speech and Language Sciences (Newcastle University, UK) in 2003. In her early career she worked as a voice clinician and quickly understood the significance of the larynx during respiration. Jemma is now an established Consultant with over 20 years’ experience working with upper airway respiratory disorders. Pioneering the role of speech therapy in UK respiratory healthcare, she developed and led two tertiary referral multidisciplinary complex breathlessness services and has co-authored numerous national professional respiratory guidelines. Jemma is extensively published with many peer reviewed publications relating to her clinical research work. Supported by a NIHR Manchester Biomedical Research Centre Research fellowship she has recently completed her doctoral studies on the evaluation and treatment of inducible laryngeal obstruction.

Jemma’s substantive post, Chief Allied Health Professional at Manchester University NHS Foundation Trust, is a strategic role with overall professional accountability for the Trust’s 2000 Allied Health Professions workforce. She is responsible for the governance and assurance of quality care and leads transformation initiatives to maximise the skills and resources of AHPs across the Trust and Greater Manchester. In the Queen’s birthday honours list in 2021, in recognition of her national leadership within the field of upper airway disorders, Jemma was made a Member of the Most Excellent Order of the British Empire. She is also a Fellow of the Royal College of Speech and Language Therapists.

Pippa Hall is the Lead Paediatric Respiratory Nurse at the Royal Brompton Hospital in London. She manages a team of 15 Respiratory Clinical Nurse Specialists. This team work as part of the wider multi-disciplinary team managing a range of different conditions including Cystic fibrosis, Primary Ciliary Dyskinesia, long term ventilation and Severe Asthma. Clinically, she looks after children, young people and families in both the in-patient and out-patient setting providing direct care, education and support. She also carries out home visits and support schools and nurseries and provides care to patients with severe asthma, pre-school wheeze.

In this role Pippa has played a large part in the development of the difficult asthma (DA) service, and this is where her interest has developed over the years.  The DA service receives around 75 referrals annually. It is a MDT led service and involves an assessment focusing on 4 main areas – adherence, smoke exposure, allergen exposure and psychosocial issues. Many of the children and young people referred are being considered for biological therapy however if remedial factors are identified and addressed such treatment can often be avoided.

Dr Sharon Hall is a Consultant in Paediatric Allergy at Imperial College Healthcare NHS Trust, with clinical and research interests in gastrointestinal allergy, complex multisystem allergic disease and integrated care. She is the lead for the Gastrointestinal allergy service at West London Children’s Hospital. She has worked with the roll out of the “Itchy sneezy wheezy” programme across outer North-West London in collaboration with CLAHRC NWL and the subsequent development of the Paediatric Allergy and Asthma Network for North and West London. She continues as faculty and mentor in the Program for Integrated Child Health (PICH) and contributes to the policy committee for PCRS. Initially trained in general practice, she subsequently trained in general paediatrics with specialist interests in allergy and gastroenterology, having developed these services as a consultant in secondary care, before subspecialising in tertiary allergy.

TBC

Dr Alpa Kanji is a scientist by background, having researched bacterial genetics for which she was awarded a PhD at the University of Cambridge. She completed her medical and dermatology training in London followed by a fellowship in paediatric dermatology at St John’s Institute of Dermatology. She is currently a consultant at St John’s Institute of Dermatology at Guy’s and St Thomas’ NHS Foundation Trust and has been part of the paediatric tertiary severe eczema service and the multidisciplinary paediatric psychodermatology service. Dr Kanji is particularly interested in atopic eczema, including the mind and skin connection, and is passionate about empowering patients to manage their skin condition as well as possible. She teaches habit reversal therapy, which encourages patients to change longstanding habits of scratching and picking their skin, and can be a helpful adjunct to conventional eczema treatments.

Professor Rebecca Knibb is Professor of Health Psychology at Aston University with 30 years of research experience in the field of asthma and allergy.  She works with multidisciplinary teams across the globe to improve the health-related quality of life and mental well-being of children, adolescents and parents who are managing allergic conditions and asthma and has published nearly 100 peer-reviewed papers in this field.  Her research group is running projects to improve understanding of allergy management and global access to psychological support for food allergy.  They are also currently developing interventions to help patients and families manage food allergy anxiety. She is the Chair of the Psychology Special Interest Group for the British Society for Allergy and Clinical Immunology and sits on the UK Expert Advisory Group for Allergy. She is also a member of European Association for Allergy and Clinical Immunology Task Force groups, including a Task Force to investigate the impact of allergy on adolescents.

Pavel Kolkhir, MD, is the Head of Healthcare Research and Chronic Spontaneous Urticaria program at the Institute of Allergology, Charité – Universitätsmedizin Berlin. He is also the Head of the Chronic Urticaria Registry (CURE) and Scientific coordinator of the UCARE network (Urticaria Centers of Reference and Excellence). His main research interest is chronic urticaria and angioedema, with more than 100 publications in peer-reviewed journals, and several book chapters published on urticaria and other mast cell-mediated diseases.

TBC

Dr Ricardo Madrigal is a Consultant Allergist serving at St Bartholomew’s Hospital, Barts Health NHS Trust, London. He specialises in drug hypersensitivity. Secretary of WAO’s Drug Hypersensitivity Reactions Committee, member of BSACI’s SOCC and UK’s Perioperative Allergy Network. He is an AAAAI fellow, prolific researcher, journal reviewer/editor, and educator.

Celia Moss is an Honorary Consultant Dermatologist at Birmingham Children’s Hospital and Honorary Professor of Paediatric Dermatology at the University of Birmingham. She trained in medicine at Oxford University and University College Hospital, London and in dermatology in Newcastle-upon-Tyne. She has chaired the British Society for Paediatric Dermatology and the NHS Clinical Reference Group for Specialised Dermatology. Following “retirement” in 2011 she still teaches, advises and publishes on genetic and paediatric dermatology. A firm believer in patient empowerment, she provides advice to several patient support groups and is a Trustee and Chair of the Medical Advisory Board of the National Eczema Society. She also serves on editorial advisory boards and provides advice to MHRA. She enjoys travel when possible, supporting colleagues particularly in India and Nepal. In 2016 she was awarded the Sir Archibald Gray Medal by the British Association of Dermatologists and an OBE for services to paediatric dermatology.

Dr Kornilia Nikaki is a Consultant in Paediatric Gastroenterology at Great Ormond Street Hospital, with sub-specialisation in the field of Neurogastroenterology. Dr Nikaki graduated with Honours from University of Thessalia, Greece in 2006 and since pursued training in General Paediatrics and later on in Paediatric Gastroenterology, Hepatology and Nutrition in the UK. Dr Nikaki was awarded a PhD from Queen’s Mary University of London in 2022 on work performed in the Wingate Institute of Neurogastroenterology on paediatric gastroesophageal reflux disease (GORD). She has served as the Chair of Gastroenterology at BSPGHAN between 2021 and 2024 and is an active member of the ESPGHAN Motility working group.

TBC

Julie qualified at Teesside University as a Paediatric Nurse with an Advanced Diploma qualification and began working in Cardiology for 5 years at the freeman Hospital in Newcastle upon Tyne, moving onto the Royal Victoria infirmary Childrens Haemodialysis unit for 10years. Working part time gave the opportunity to work shifts in the paediatrics A& E to broaden her general Paediatric knowledge.

Over the past 10 years she has worked with the Allergy Team and is currently the Band 7 Lead clinical Allergy Nurse Specialist at Children’s and Young Persons Allergy at the Great North Children’s Hospital in Newcastle.

At Northumbria University She completed her BSc Hons Degree in nursing studies in December 2017 with a 2:1, her dissertation was on Auto adrenaline injectors and training into emergency care setting. Julie has now completed her MSc in allergy at the University of Southampton and is awaiting results.

Dr Leyla Pur Ozyigit is a Consultant in Adult Allergy at University Hospitals of Leicester NHS Trust and an Honorary Associate Professor at the University of Leicester. She has a PhD in Immunology and holds European board certifications in both Allergy and Respiratory Medicine.

She completed allergy training in Montpellier, France, and pursued a clinical observership in drug desensitization at Brigham and Women’s Hospital in Boston, USA. Dr Ozyigit held academic and clinical positions in Istanbul, Turkey. Her clinical and research interests include drug hypersensitivity, anaphylaxis, asthma, nasal polyposis, and the innate immune system.

She serves on the BSACI Standards of Care Committee and is a member of both the NSAID Hypersensitivity Guideline Working Group and the Rhinosinusitis and Nasal Polyposis Guideline Group. She previously served as Secretary of the EAACI Ethics Committee and currently serves on the EAACI Scientific Communication Committee. She is also an Associate Editor of the Thoracic Research and Practice Journal.

Jennifer Quint is a Professor of Respiratory Epidemiology in the School of Public Health at Imperial College London. She is an Honorary Consultant Physician in Respiratory Medicine at both the Royal Brompton Hospital and Imperial College London NHS Foundation Trust. Prof Quint leads the Respiratory Electronic Health Record group, a clinical epidemiology research group whose interests centre on using various sources of de-identified, routinely collected electronic healthcare records to study a number of respiratory diseases including chronic obstructive pulmonary disease (COPD), asthma, interstitial lung disease, bronchiectasis and most recently COVID-19. Work centres on maximising the quality, linkage and usage of these data for clinical and research purposes. Research topics include understanding the relationship between cardiovascular and respiratory disease, respiratory disease prevention, diagnosis, natural history and management. Many of the outputs are used for informing policy, and in the planning and allocation of resources. She is a Fellow of the Higher Education Academy and the Royal College of Physicians. She leads NHSEngland’s Respiratory Data Strategy and is the Associate Director for the HDR UK A+LUK Respiratory Data Catalyst. She partners with the Royal College of Physicians where she is the Analysis Lead for the National Respiratory Audit Programme and is co-lead of the HDR UK Inflammation and Immunity Driver Program. She currently serves as joint Editor-in-chief of the journal Thorax. Prof Quint is a Deputy Director (Academic) of the Early Career Researcher Institute (ECRI), leads several Research Portfolios on the Global Masters in Public Health and is involved in teaching and supervising projects across MBBS, and Masters programs.

Matthew Ridd is a GP, NIHR Research Professor, Professor of Primary Health Care and Director of the Centre for Applied Excellence in Skin & Allergy Research (CAESAR), which sits within the Centre of Academic Primary Care (www.bristol.ac.uk/capc), one of the founding members of the NIHR School for Primary Care Research, at the University of Bristol, UK.

His main research interests are the diagnosis and treatment of skin and allergy problems commonly seen in primary care.  His main methodological expertise is in clinical trials, qualitative research, and systematic reviews.

He has won RCGP “Research paper of the year” three times, including for the Best Emollients for Eczema (www.bristol.ac.uk/bee-study) study.  In recognition of the clinical importance of his research, became a Fellow of the Royal College of General Practitioners (RCGP) in 2016 and in 2017 was awarded the RCGP John Fry award.

He is currently leading two national clinical trials (Amitriptyline for the prevention of Postherpetic Nearalgia, www.bristol.ac.uk/athena-study and Trial of IgE food allergy tests for eczema relief, www.bristol.ac.uk/tiger-study), and a programme of work (Transforming outcomes for paediatric allergy in primary Care, www.bristol.ac.uk/topic-study) around eczema and food allergy in children.

Sinisa Savić is a Professor of Clinical Immunology at the University of Leeds and an Honorary Consultant Immunologist at St James’s University Hospital.

Professor Savić has led a regional immunology service providing specialist care for adult patients with primary and secondary immunodeficiencies, allergic conditions, and systemic autoinflammatory syndromes. He currently chairs the Clinical Immunology Professional Network at the British Society for Immunology and serves as Deputy Director of the NIHR Leeds Biomedical Research Centre.

His translational research focuses on the molecular mechanisms underpinning inborn errors of immunity and acquired immune-mediated diseases. He has contributed to the discovery of several novel immunological disorders and has been Principal Investigator in numerous clinical trials involving hereditary angioedema and chronic urticaria.

Glenis Scadding is an Honorary Consultant Physician, Royal National ENT Hospital, London and Honorary Associate Professor in Division of Immunity and Infection, University College London. She trained at Cambridge University and the Middlesex Hospital, to which she later returned as an allergy trainee under Jonathan Brostoff and Ivan Roitt.

She is also EUFOREA Vice President and Lead for Rhinitis and Scientific Chief Editor for Rhinology Section, Frontiers in Allergy.

Glenis is a BSACI Past President and has been awarded the BSACI William Frankland medal for outstanding services to UK Clinical Allergy. In 2020 she gave the BSACI Jack Pepys Lecture. She was Allergy UK Allergist of the Year in 2011, has received the European Academy of Allergy and Immunology Clemens von Pirquet award for research, the British Medical Association Walter Jobson Horne Award and World Allergy Organization -Outstanding Clinician award.

Glenis’ research interests include rhinitis and its co-morbidities, including asthma and rhinosinusitis; aspirin hypersensitivity and sublingual immunotherapy. She is the author of over 400 peer- reviewed publications (H index 85) and of 2 novels, proceeds from which go to dementia research.

TBC

Dr Skypala qualified as a dietitian in 1979. She established a bespoke adult food allergy service at the Royal Brompton & Harefield Hospitals in 2008, and in 2014 became the UKs first consultant adult allergy dietitian. She is also a senior clinical lecturer at Imperial College London. Her research focus is on Pollen Food Syndrome, and Lipid Transfer Protein Allergy and she has published over 90 peer-reviewed papers. Dr Skypala has been active in the British Society of Allergy & Clinical Immunology (BSACI) for over 20 years and currently co-chairs the Standards of Care Committee. She also chairs the Food Allergy Interest Group of European Academy of Allergy & Clinical Immunology and leads the Plant Food Allergy Workgroup of the American Academy of Allergy, Asthma and Immunology (AAAAI). Together with others, Dr Skypala has spent the last 25 years establishing dietetic specialist allergy groups in the UK, Europe, and the USA. She received the BSACI William Frankland award for services to clinical allergy in 2014, and the Allied Health Professional Recognition Award from the AAAAI in 2022.

James Thaventhiran is a clinical immunologist with an interest in personalised medicine approaches to improve health outcomes. He completed clinical training in St. Bartholomew’s and the Royal Free Hospital and since 2014 has worked as a clinical academic at the University of Cambridge and Addenbrookes hospitals. His work in next generation sequencing has uncovered monogenic causes for atopic diseases and he is now working toward harnessing the personalisation potential for mRNA therapies to address rare and common disease.

TBC

Professor Sanna Toppila-Salmi Lab studies pathomechanisms, genomics, epidemiology and clinical management of chronic inflammatory airway diseases, such as CRSwNP, asthma, allergy and N-ERD. Professor Toppila-Salmi has published over 200 peer-reviewed international articles. She is the past Chair of the ENT Section of EAACI, and the Associate Editor of Clinical and Translational Allergy and Rhinology Journals.

Dr Paul Turner is Professor of Anaphylaxis, Paediatric Allergy & Clinical Immunology at Imperial College London. His research focusses on the pathophysiology of severe allergic reactions to food, and how this impacts upon allergen risk management and allergen labelling. Paul is a consultant to the UK Health Security Agency (UKHSA) and a previous senior advisor to the UK Food Standards Agency. He is vice-chair of the UK’s National Allergy Strategy Group, and current chairperson of the WAO Anaphylaxis Committee. Paul was the recipient of the 2020 PhARf Award, awarded by the European Academy of Allergy & Clinical Immunology.

Prof. Jolanta Walusiak-Skorupa, MD, PhD, is a specialist in occupational medicine and clinical toxicology and the Director of the Nofer Institute of Occupational Medicine in Łódź, Poland. Since 1992, she has been professionally affiliated with the Department of Occupational Diseases and Environmental Health.

Prof. Walusiak-Skorupa is a recognized leader in occupational allergy research. Her scientific interests include immediate-type occupational allergy in selected professional groups, risk factors for occupational asthma, diagnostic methods and phenotyping of work-related allergic diseases, as well as respiratory biomarkers of exposure. She has led numerous national prevention programs and co-developed practical guidelines for occupational health surveillance and the reintegration of workers with disabilities.

Since 2019, she has served on the Executive Committee of the European Academy of Allergy and Clinical Immunology (EAACI), where she also chaired the Occupational Allergy Interest Group. In 2024, she was appointed Vice President for Education and Specialty of EAACI. She represents Poland in the UEMS Section of Occupational Medicine and has been a member of Collegium Ramazzini since 2021.

An active academic mentor and postgraduate educator, she has promoted four PhD candidates and supported the academic advancement of her clinical team. She also serves as the Regional Consultant in Occupational Medicine for the Łódź region and is President of the Polish Society of Occupational Medicine.

Dr Watts is a Consultant Physician in Adult Allergy. His substantive consultant post is based at Homerton Healthcare NHS Foundation Trust, London, where he leads the drug allergy service. He was appointed Clinical Lead for Allergy at Homerton Healthcare in 2024.

He is also an Honorary Clinical Senior Lecturer at Imperial College London, where he is a faculty member on the MSc Allergy postgraduate programme.

Dr Watts qualified from Barts and The London Medical School and was later awarded a competitive NIHR Academic Clinical Fellowship in Allergy. He completed specialty training in Adult Allergy within Guy’s & St Thomas’ Hospitals.

Dr Watts has specialist clinical and research interests in delayed (Type IV) drug hypersensitivity and has published widely in this field. He additionally developed and leads a tertiary drug patch testing service at Homerton University Hospital, which functions as a regional referral centre within London for the investigation of delayed-type drug eruptions. His clinical research in particular focuses on the utility, methodology, efficacy and safety of Drug Patch Testing, and the wider investigation of Delayed (Type IV) T-cell mediated drug hypersensitivity reactions. He is also a Member of the WAO Drug Hypersensitivity Reactions Committee, and an active FRCPath examiner.

Dr Andrew Whyte trained in Australia before moving to the UK in 2014. He is a Consultant Allergist and Immunologist in Plymouth where his interests are particularly in anaphylaxis, venom allergy, and clonal mast cell disorders. He leads University Hospitals Plymouth as a European Competence Network on Mastocytosis Centre of Excellence.

Dr Austen Worth has been a Paediatric Immunologist at Great Ormond Street Hospital (GOSH), and associate professor at UCL since 2013. His clinical work focuses on the diagnosis and management of severe immunodeficiency, including haematopoietic stem cell transplant, gene therapy, thymic transplant, and the development of novel targeted therapies.

Dr Worth’s undergraduate training was at Oxford University. He undertook doctoral and post-doctoral research at the UCL Institute of Child Health on the molecular pathophysiology of Wiskott Aldrich Syndrome and dendritic cell motility defects. Subsequently his research interests have broadened to include thymic transplantation, EBV infection in immunodeficient hosts, XIAP deficiency, and immunedysregulatory disorders. He has over 100 publications in peer reviewed journals and is principal investigator on 5 clinical trials/studies.

He is Associate Medical Director for Therapeutics at GOSH and since 2024 has been clinical lead for the European Thymic Transplantation program. He is on the scientific committee for the EBMT Inborn Errors Working Party, the steering committee for the British Society of Immunology Clinical Immunology Professional Network (BSI-CIPN) and the UK Immunodeficiency (UKPID) Registry committee. He has previously worked in health development in sub-Saharan Africa, and was Chair of the RCPCH-VSO Fellowship committee for 4 years.

Karen is a paediatric specialist dietitian and a senior research fellow in Dietetics at the University of Southampton. Karen has specialised in the field of food allergy for many years in the UK and overseas and is the past joint chair of the British Dietetic Association Food Allergy Specialist Group and is currently co-chair of the BSACI Dietitians Interest Group.

Karen is currently working towards a PhD in food allergy, continuing her commitment to advancing knowledge and supporting parents.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.